Skip to main content

UPDATE 1-Canada says working with U.S. FDA to address EpiPen shortage

TORONTO, April 17 (Reuters) - Canada's government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan N.V.'s EpiPen emergency allergy antidote that has hit several countries outside of the United States, where it is manufactured.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.